Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NIGA-RA: Anti-hinge Antibodies in IgA Nephropathy
NCT02526966Completed
- Sponsor
- CHU Saint-Etienne
- Start
- Mar 2012
- Primary completion
- Jun 2014
- Countries
- 1
01
Overview
Single-arm trial, sponsored by CHU Saint-Etienne. Primary endpoint: Serum concentration of anti-hinge region antibodies. Started Mar 2012; status: completed.
Beyond the preview
Go deeper on NCT02526966.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02526966.